Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2025 08:55 ET | Source: PharmAla Biotech

PharmAla Issues Q2 Financial Statements

PharmAla releases Q2 financial statements showing increased customer deposits, shipments
May 03, 2024 11:00 ET | Source: PharmAla Biotech

PharmAla Launches Prescriber’s Portal for Medical Professionals Focused on MDMA Therapy

PharmAla launches new educational resource for prescribers of MDMA through the Special Access Program
April 10, 2024 16:30 ET | Source: PharmAla Biotech

PharmAla Announces Private Placement and Concurrent Debt Settlement

PharmAla Initiates $750,000 Private Placement with concurrent debt settlement, anticipated to close on April 17th 2024
March 26, 2024 08:55 ET | Source: PharmAla Biotech

PharmAla Biotech Signs Sale Agreement with Numinus

PharmAla announces binding sales order from Numinus Wellness, as well as a recent presentation of data to the Behaviour, Biology, and Chemistry Conference
March 18, 2024 08:55 ET | Source: PharmAla Biotech

Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme

PharmAla's 50:50 Joint Venture with Vitura Health Limited, Cortexa, announces it is first entity to supply Psilocybin into Authorized Prescriber Scheme
January 25, 2024 12:09 ET | Source: PharmAla Biotech

PharmAla granted a Controlled Drugs & Substances Dealer’s License by Health Canada

PharmAla granted a Health Canada Controlled Drugs and Substances Dealer's License
November 09, 2023 08:55 ET | Source: PharmAla Biotech

World’s First Observational Trial to Assess Real-World Efficacy of MDMA Treatment

PharmAla partners with Heroic Hearts Canada and the University of Calgary to launch the world's first observational rial into MDMA's real-world efficacy
May 16, 2023 11:37 ET | Source: PharmAla Biotech

PharmAla Biotech and Shaman Pharma Granted First Ever Special Access Program Authorization for MDMA

VANCOUVER, British Columbia, May 16, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA), a biotechnology company focused on the research, development, and manufacturing...
April 11, 2023 08:00 ET | Source: PharmAla Biotech

PharmAla Biotech and Filament Health Announce Release of GMP MDMA Capsules

VANCOUVER, British Columbia, April 11, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE:MDMA), a Canadian biotechnology company dedicated to the research and development of...